Revolutionizing medicine in the 21st century through systems approaches

被引:153
作者
Hood, Leroy [1 ]
Balling, Rudi [2 ]
Auffray, Charles [3 ]
机构
[1] Inst Syst Biol, Seattle, WA 98109 USA
[2] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg
[3] Univ Lyon, CNRS, ENS, European Inst Syst Biol & Med,UCBL, Lyon, France
关键词
Functional genomics; Network biology; Personalized medicine; Systems medicine; MICROSCOPY; DISEASES; CANCER;
D O I
10.1002/biot.201100306
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Personalized medicine is a term for a revolution in medicine that envisions the individual patient as the central focus of healthcare in the future. The term personalized medicine, however, fails to reflect the enormous dimensionality of this new medicine that will be predictive, preventive, personalized, and participatory-a vision of medicine we have termed P4 medicine. This reflects a paradigm change in how medicine will be practiced that is revolutionary rather than evolutionary. P4 medicine arises from the confluence of a systems approach to medicine and from the digitalization of medicine that creates the large data sets necessary to deal with the complexities of disease. We predict that systems approaches will empower the transition from conventional reactive medical practice to a more proactive P4 medicine focused on wellness, and will reverse the escalating costs of drug development an will have enormous social and economic benefits. Our vision for P4 medicine in 10 years is that each patient will be associated with a virtual data cloud of billions of data points and that we will have the information technology for healthcare to reduce this enormous data dimensionality to simple hypotheses about health and/or disease for each individual. These data will be multi-scale across all levels of biological organization and extremely heterogeneous in type this enormous amount of data represents a striking signal-to-noise (S/N) challenge. The key to dealing with this S/N challenge is to take a holistic systems approach to disease as we will discuss in this article.
引用
收藏
页码:992 / 1001
页数:10
相关论文
共 22 条
  • [1] [Anonymous], GENET ENG BIOTECHNOL
  • [2] Systems medicine: the future of medical genomics and healthcare
    Auffray, Charles
    Chen, Zhu
    Hood, Leroy
    [J]. GENOME MEDICINE, 2009, 1
  • [3] Diseases as network perturbations
    del Sol, Antonio
    Balling, Rudi
    Hood, Lee
    Galas, David
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2010, 21 (04) : 566 - 571
  • [4] External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease
    Fens, N.
    Roldaan, A. C.
    van der Schee, M. P.
    Boksem, R. J.
    Zwinderman, A. H.
    Bel, E. H.
    Sterk, P. J.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (10) : 1371 - 1378
  • [5] Nontargeted Elucidation of Metabolic Pathways Using Stable-Isotope Tracers and Mass Spectrometry
    Hiller, Karsten
    Metallo, Christian M.
    Kelleher, Joanne K.
    Stephanopoulos, Gregory
    [J]. ANALYTICAL CHEMISTRY, 2010, 82 (15) : 6621 - 6628
  • [6] Predictive, personalized, preventive, participatory (P4) cancer medicine
    Hood, Leroy
    Friend, Stephen H.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (03) : 184 - 187
  • [7] A systems approach to prion disease
    Hwang, Daehee
    Lee, Inyoul Y.
    Yoo, Hyuntae
    Gehlenborg, Nils
    Cho, Ji-Hoon
    Petritis, Brianne
    Baxter, David
    Pitstick, Rose
    Young, Rebecca
    Spicer, Doug
    Price, Nathan D.
    Hohmann, John G.
    DeArmond, Stephen J.
    Carlson, George A.
    Hood, Leroy E.
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2009, 5
  • [8] Kuhn T. S., 1962, STRUCTURE SCI REVOLU
  • [9] Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB
    Langen, RCJ
    Schols, AMWJ
    Kelders, MCJM
    Wouters, EFM
    Janssen-Heininger, MW
    [J]. FASEB JOURNAL, 2001, 15 (07) : 1169 - 1180
  • [10] Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1
    Millward, Steven W.
    Henning, Ryan K.
    Kwong, Gabriel A.
    Pitram, Suresh
    Agnew, Heather D.
    Deyle, Kaycie M.
    Nag, Arundhati
    Hein, Jason
    Lee, Su Seong
    Lim, Jaehong
    Pfeilsticker, Jessica A.
    Sharpless, K. Barry
    Heath, James R.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (45) : 18280 - 18288